CURE

VanEck Genomics and Healthcare Innovators UCITS ETF

Underlying Index
MVIS^® Global Future Healthcare ESG Index (MVFHCTR)

The Index Composition:

The MVIS Global Future Healthcare ESG Index (MVFHCTR) tracks the performance of the largest and most liquid companies that are involved in the genomic health care and electronic healthcare industries. MVFHCTR covers at least 90% of the investable universe and adheres to ESG criteria.

Companies initially eligible for inclusion in Index:

• Companies involved in genomic health care or electronic healthcare industries. This includes companies with at least 50% (25% forcurrent components) of their revenues from the following sub-themes:
1. Healthcare therapies based on the targeting or modification of genetic makeup of cells or uses mRNA
2. Technology platforms that enable the development of genetics-based healthcare therapies
3. Laboratory equipment or services used to test, code, or develop genetics-based healthcare therapies
4. Software used to facilitate online medical consultations
5. E-Commerce pharmacies
6. Software for the management of medical practices and/or patient records
7. Outpatient medical IoT devices
• Market capitalization greater than $150 million
• Three-month average daily turnover greater than $1 million
• Minimum trading volume of 250,000 shares each month over last 6 months
• Company weightings are capped at 8%.

MVIS